Lonza and Moderna announce further manufacturing collaboration

In May 2020, the companies announced a ten-year strategic collaboration agreement to enable the manufacture of the vaccine and additional Moderna products in the future

picture of

Breaking News

Lonza to supply prequalified cells for CN Bio OOC technology

Organ-on-a-chip technology has the potential to solve the issues presented by 2D cell cultures and animal models, the ...

Minaris to manufacture Bluebird Bio therapy for CALD

Early Cerebral Adrenoleukodystrophy is a life-threatening progressive neurodegenerative disease

Nanopharm and Leyden Labs to develop nasal sprays for virus protection

Leyden Labs’ platform targets commonalities of viral families to develop candidates that protect against many strains ...

Decentralised manufacturing: how outsourcing is helping to bring the personalised medicine promise to reality

Personalised medicine represents a revolution in healthcare strategies. Combining traditional clinical information with ...

Aptamer Group and WuXi AppTec collaborate on Optimer therapeutics

As part of the agreement, Aptamer will develop Optimers to specific disease biomarkers and supply them to WuXi for ...

Vetter completes integration of Austrian manufacturing site

The site currently offers 100,000 sqft of offices, laboratory space, areas for material preparation

Taking a lifecycle approach to fill-finish success

Dr Kevin Robinson recently spoke to swissfillon founder and CEO, Daniel Kehl, and Business Development Director, Carole ...

Lonza extends partnership with major biopharma partner

The announcement develops of an existing customer relationship under which the CDMO provides highly potent payload, ...

Recipharm invests in fill finish capacity in India

The facility will complement the company’s three other sterile filling capabilities in France, Germany and Italy

Oncolytic viruses: the key to advancing novel therapies to market

As researchers continue to uncover and understand the enormous complexities of cancer, emerging technology and novel ...

Harnessing the power of HPAPIs: key considerations

Adam Kujath, Senior Director at Sterling Pharma Solutions, discusses the key issues that companies need to consider ...

Outsourcing partners provide strong backbone for brands in post-COVID reality

Today, brands and retailers are relying more than ever on the robustness and agility of their “under the radar” ...

ExeVir and Mithra announce manufacturing collaboration

Mithra CDMO will perform fill finish work for XVR011, ExeVir’s COVID-19 antibody therapy

Thermo Fisher and UC Davis launch metabolomics centre

Metabolomics is a field where researchers identify diagnostic biomarkers for disease, discover drug targets, develop ...